Skip to main content

OTCMKTS:OTSKF - Otsuka Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$39.29
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Otsuka Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OTSKF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OTSKF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Otsuka in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $39.29.

N/A

The current consensus among 0 investment analysts is to n/a stock in Otsuka. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/14/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/10/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/7/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/21/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
i
(Data available from 5/8/2016 forward)
Otsuka logo
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of central nervous system, oncology, cardiovascular system, gastroenterology, ophthalmology, diagnostics, and I.V. solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÃ Jelly, a conditioning food product; BODYMAINTÃ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; SOYJOY, a soy bar; OS-1, an oral rehydration solution; HINE E-GEL, a concentrated liquid diet; PROCESSLEAD, a chew and swallow managing food; REHADAYS, a beverage to support exercise and rehabilitation; Oronine H Ointment, a household antiseptic medicine; and vitamin tonics, herbal digestive drinks, and herbal crude drugs. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 2008 and is headquartered in Tokyo, Japan.
Read More

Today's Range

Now: $39.29
$39.29
$39.29

50 Day Range

MA: $41.76
$39.29
$44.31

52 Week Range

Now: $39.29
$38.10
$46.02

Volume

63 shs

Average Volume

1,429 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Otsuka?

The following Wall Street analysts have issued research reports on Otsuka in the last year:
View the latest analyst ratings for OTSKF.

What is the current price target for Otsuka?

0 Wall Street analysts have set twelve-month price targets for Otsuka in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Otsuka in the next year.
View the latest price targets for OTSKF.

What is the current consensus analyst rating for Otsuka?

Otsuka currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for OTSKF.

What other companies compete with Otsuka?

Other companies that are similar to Otsuka include Daiichi Sankyo, ePlus, Medipharm Labs, Ono Pharmaceutical and OTCMKTS:WDEXF.

How do I contact Otsuka's investor relations team?

The company's listed phone number is (136) 717-1410. The official website for Otsuka is www.otsuka.com.